$18.3
Currently 14 wall-street analysts regularly analyze the financials of Celldex Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 14 analysts offering 12-month price forecasts for Celldex Therapeutics, Inc. (CLDX) have a share price target of $62.08. This median of share price forecast represents a 239.25% upside from the latest price of $18.3 as on 22.04.25.
As per the chart shown above, analysts believe that the Celldex Therapeutics, Inc. (CLDX) share price will touch around $62.08 in next 12-months.
Below is a chart showing the percentage difference between Celldex Therapeutics, Inc.'s share price and its median forecast price. As on 22.04.25, the difference is -72.86%
Based on 14 analysts tracking and researching Celldex Therapeutics, Inc. (CLDX) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 7 | 7 | 7 |
Outperform | 5 | 5 | 5 |
Hold | 2 | 2 | 2 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |